PROVECTUS BIOPHARMACEUTICALS, INC.
PVCTDrugs in Pipeline
5
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
PV-10 (10% rose bengal disodium)
Melanoma
PH-10 (0.002% Rose Bengal)
Psoriasis
Topical Rose Bengal, 0.005%
Psoriasis
PH-10
Atopic Dermatitis
PH-10 (0.001% Rose Bengal)
Psoriasis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PV-10 (10% rose bengal disodium) | Phase 2 | Melanoma | - | - |
PH-10 (0.002% Rose Bengal) | Phase 2 | Psoriasis | - | - |
Topical Rose Bengal, 0.005% | Phase 2 | Psoriasis | - | - |
PH-10 | Phase 2 | Atopic Dermatitis | - | - |
PH-10 (0.001% Rose Bengal) | Phase 2 | Psoriasis | - | - |
Frequently asked questions
What is in PROVECTUS BIOPHARMACEUTICALS, INC.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in PROVECTUS BIOPHARMACEUTICALS, INC.'s (PVCT) pipeline across Phase 2. Its lead program is PV-10 (10% rose bengal disodium) (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PROVECTUS BIOPHARMACEUTICALS, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PVCT biotech catalysts?→
Add PVCT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PROVECTUS BIOPHARMACEUTICALS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.